Source: Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Gaga (Athens, Greece). The evaluation and biomarkers of severe asthma. Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force

Member's Comments

No comment yet.

Related content which might interest you: Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 What can we learn from models to study exacerbation mechanisms in asthma and COPD? Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Immunotherapy in severe asthma Source: ERS webinar 2021: Immunotherapy in severe asthma Year: 2021 Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 COPD: An outcome of childhood asthma? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010 Ykl-40 and phenotyping of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Work-related asthma and occupational asthma: clinical approach Source: Annual Congress 2005 - Occupational asthma Year: 2005 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Clinical control of asthma associated with measures of airway inflammation Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021